Equities

Diaceutics PLC

DXRX:LSE

Diaceutics PLC

Health CareHealth Care Providers
  • Price (GBX)114.50
  • Today's Change4.50 / 4.09%
  • Shares traded642.06k
  • 1 Year change36.31%
  • Beta0.4495
Data delayed at least 20 minutes, as of May 17 2024 11:53 BST.
More ▼

Profile data is unavailable for this security.

About the company

Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Company’s DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.

  • Revenue in GBP (TTM)21.90m
  • Net income in GBP6.00k
  • Incorporated2005
  • Employees151.00
More ▼

Peer analysis

CompanyRevenue (TTM)Net income (TTM)Market capEmployeesMarket Cap /
Employees
Made Tech Group PLC38.78m-1.51m25.75m430.0025.75m430.00
Vianet Group PLC14.13m67.00k34.13m141.0034.13m141.00
TRIAD GROUP PLC14.13m-632.00k46.11m115.0046.11m115.00
Argo Blockchain PLC39.81m-27.59m66.25m30.0066.25m30.00
Diaceutics PLC21.90m6.00k96.99m151.0096.99m151.00
Spectra Systems Corp15.98m4.76m119.31m--119.31m--
Iomart Group Plc125.12m6.60m161.58m445.00161.58m445.00
Redcentric PLC162.14m-13.00m208.90m638.00208.90m638.00
Seeing Machines Ltd46.56m-23.57m211.82m399.00211.82m399.00
Capita PLC2.81bn-178.10m248.05m43.00k248.05m43.00k
FD Technologies PLC291.10m-11.06m362.33m2.80k362.33m2.80k
Restore PLC277.10m-30.70m377.91m2.64k377.91m2.64k
NCC Group PLC315.10m-14.20m423.21m2.43k423.21m2.43k
Data as of May 17 2024. Currency figures normalised to Diaceutics PLC's reporting currency: UK Pound GBX

Institutional shareholders

42.25%Per cent of shares held by top holders
HolderShares% Held
Canaccord Genuity Wealth Ltd.as of 31 Dec 20227.81m9.22%
Gresham House Asset Management Ltd. (Investment Management)as of 31 Jan 20245.70m6.74%
Joh. Berenberg, Gossler & Co. KG (Investment Management)as of 31 Dec 20225.44m6.42%
Universal-Investment-Gesellschaft mbH (Invt Mgmt)as of 26 Sep 20234.01m4.73%
Danske Bank A/S (Investment Management)as of 20 Nov 20233.87m4.57%
Herald Investment Management Ltd.as of 31 Dec 20203.01m3.56%
Handelsbanken Fonder ABas of 30 Apr 20241.87m2.20%
River Global Investors LLPas of 01 Apr 20241.50m1.77%
EdenTree Investment Management Ltd.as of 01 Apr 20241.41m1.66%
Avellemy Ltd.as of 30 Apr 20241.17m1.38%
More ▼
Data from 31 Jan 2024 - 30 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.